Technology News and Research

RSS

Intrexon to deploy Novici's GRAMMR technology in concert with UltraVector platform

Intrexon Corporation, a next generation synthetic biology company, today announced an agreement with Novici Biotech LLC in which Intrexon has licensed certain non-exclusive rights to the use of Novici's patented GRAMMR® technology for high-resolution genetic reassortment ("gene shuffling").

9 May 2011

Advanced Cell Technology first quarter net loss decreases to $3.3 million

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today first quarter financial results for the period ended March 31, 2011. The Company reported a loss from operations of $(4.8) million compared to a loss from operations of $(15.0) million in the 2010 first quarter.

9 May 2011

Lovelace signs definitive agreement to acquire Heart Hospital of New Mexico

Lovelace Health System, Inc. has signed a definitive agreement to purchase the assets and operations of the Heart Hospital of New Mexico from MedCath Corporation for $119 million.

9 May 2011

IOD announces expanded capabilities to address top health information management challenges

IOD Incorporated, a leading provider of integrated HIM solutions to hospitals, health systems, and physician practices, today announced expanded capabilities to address health information management's top three challenges of this decade: transitioning to ICD-10, implementing electronic records and recruiting highly qualified HIM staff.

9 May 2011

Ellman International launches Pelleve GlideSafe handpieces for wrinkle treatment

Ellman International, Inc., maker of the Pelleve Wrinkle Reduction System, a revolutionary skin tightening system for non-ablative skin rejuvenation, introduced its new family of GlideSafe™ handpieces this week at the American Society for Aesthetic Plastic Surgery's 44th Annual Meeting at the Boston Convention & Exhibition Center.

9 May 2011

Illumina announces price reduction in whole human genome sequencing projects

Illumina, Inc. today announced that it is significantly reducing the price for sequencing whole human genomes through the Illumina Genome Network.

From Illumina, Inc. 9 May 2011

caprotec bioanalytics closes Series B financing for EUR 5 million

caprotec bioanalytics GmbH, a privately held biopharmaceutical company offering the proprietary Capture Compound Mass Spectrometry platform technology for the analysis of small molecule – protein interactions, today announced a second closing of EUR 1 million to its Series B financing, increasing total equity for the round to EUR 5 million.

9 May 2011

OncoSec's tumor-destroying, tissue-sparing drug/device system profiled in Medical Device Daily

OncoSec Medical Inc., a therapeutic oncology company developing innovative medical approaches to treat solid tumor cancers with unmet medical needs, announced today the cancer therapy company's tumor-destroying, tissue-sparing drug/device technology was profiled in Medical Device Daily, the news source for the high-tech medical technology industry that is relied on by thousands of industry insiders every business morning.

9 May 2011

Flamel Technologies total revenues decrease to $6.8 million for first quarter 2011

Flamel Technologies today announced its financial results for the first quarter of 2011.

9 May 2011

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Affymetrix, Inc. today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories to its GeneChip Microarray Instrument System for in vitro diagnostic use, making Affymetrix the first in the industry to provide a comprehensive microarray-based clinical toolkit for diagnostic test development, signature discovery for companion diagnostics, and translational initiatives. Affymetrix Gene Profiling Reagents offer unparalleled convenience by simplifying assay workflow, decreasing hands-on time, and reducing quality control testing compared to research-use-only-produced products.

9 May 2011

Heptares, Shire sign deal to develop novel A2A antagonist for CNS disease treatment

Heptares Therapeutics today announced it has signed an exclusive option agreement with Shire Pharmaceuticals for a novel adenosine A2A antagonist discovered by Heptares and currently in preclinical development.

9 May 2011

Philips, IBA enter agreement to establish proton therapy center for patients

IBA Group, a leader in advanced cancer diagnosis and therapy technologies and Royal Philips Electronics, today announced they have entered into an agreement to create state of the art patient-centric proton therapy centers.

From Philips Healthcare 9 May 2011

Elan Drug Technologies, Alkermes merge to form new company in Ireland

Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.

9 May 2011

New international project to create more mutant genes, address shortage of Cre resources

Local scientists are now part of an International team compiling an enormous bank of resources for research into the functions of all known genes. The development of these biological resources will eventually allow scientists to know how the human genome behaves in health and disease.

9 May 2011

MaxID wins 1000-unit sale of iDL500 multi-modal mobile computer in South Africa

MaxID Pty Ltd, a wholly owned company of MaxID Corp, a leading provider of mobile identity solutions, is pleased to announce that it has won a 1000-unit sale of its iDL500 units in South Africa.

9 May 2011

NYU Langone researchers present recent findings at The Heart Rhythm Society 32nd annual sessions

Cardiologists from the Cardiac & Vascular Institute at NYU Langone Medical Center presented new research at The Heart Rhythm Society's 32nd Annual Scientific Sessions, May 4 -7 in San Francisco, California.

9 May 2011

Objet's 3D printing dental solutions to be showcased at LMT LAB DAY West

Objet Geometries Ltd., the innovation leader in 3D printing for rapid prototyping and additive manufacturing, will demonstrate the benefits of adding 3D printing to the workflow, at LMT LAB DAY West.

7 May 2011

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.

7 May 2011

Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the prestigious journal Current Opinion in Immunology has published an article in its current issue entitled, "Electroporation Delivery of DNA Vaccines: Prospects for Success."

7 May 2011

Paragon's offerings and solutions to be showcased at EMC World Conference

Paragon Solutions, a business and information technology consulting firm, announced today that it will be showcasing its offerings and solutions at the 2011 EMC World Conference from May 9th to May 12th at the Venetian Hotel and Casino in Las Vegas, Nevada.

7 May 2011

Technology News and Research

Intrexon to deploy Novici's GRAMMR technology in concert with UltraVector platform

Advanced Cell Technology first quarter net loss decreases to $3.3 million

Lovelace signs definitive agreement to acquire Heart Hospital of New Mexico

IOD announces expanded capabilities to address top health information management challenges

Ellman International launches Pelleve GlideSafe handpieces for wrinkle treatment

Illumina announces price reduction in whole human genome sequencing projects

caprotec bioanalytics closes Series B financing for EUR 5 million

OncoSec's tumor-destroying, tissue-sparing drug/device system profiled in Medical Device Daily

Flamel Technologies total revenues decrease to $6.8 million for first quarter 2011

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Heptares, Shire sign deal to develop novel A2A antagonist for CNS disease treatment

Philips, IBA enter agreement to establish proton therapy center for patients

Elan Drug Technologies, Alkermes merge to form new company in Ireland

New international project to create more mutant genes, address shortage of Cre resources

MaxID wins 1000-unit sale of iDL500 multi-modal mobile computer in South Africa

NYU Langone researchers present recent findings at The Heart Rhythm Society 32nd annual sessions

Objet's 3D printing dental solutions to be showcased at LMT LAB DAY West

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

Paragon's offerings and solutions to be showcased at EMC World Conference

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News